Lista de obras -

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

artículo científico publicado en 2010

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

artículo científico publicado en 2013

Analysis of 34 candidate genes in bupropion and placebo remission

artículo científico publicado en 2012

Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors

scientific article published on 01 March 2020

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

artículo científico publicado en 2017

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia

artículo científico publicado en 2019

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

scientific article published on 23 April 2020

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

artículo científico publicado en 2013

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

artículo científico publicado en 2015

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

artículo científico publicado en 2009

Association study between the neurexin-1 gene and tardive dyskinesia

artículo científico publicado en 2017

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

artículo científico publicado en 2012

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

artículo científico publicado en 2005

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

scientific article published on 15 August 2018

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

artículo científico publicado en 2015

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

artículo científico publicado en 2010

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

artículo científico publicado en 2010

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

artículo científico publicado en 2006

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia

artículo científico publicado en 2009

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

artículo científico publicado en 2013

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

artículo científico publicado en 2016

Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia

artículo científico publicado en 2020

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

artículo científico publicado en 2013

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

artículo científico publicado en 2018

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

artículo científico publicado en 2006

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

artículo científico publicado en 2014

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

artículo científico publicado en 2016

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain

artículo científico publicado en 2011

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

artículo científico publicado en 2009

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

artículo científico publicado en 2008

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

artículo científico publicado en 2017

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

artículo científico publicado en 2018

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

artículo científico publicado en 2014

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

artículo científico publicado en 2014

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans

artículo científico publicado en 2019

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

artículo científico publicado en 2007

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

artículo científico publicado en 2016

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

artículo científico publicado en 2015

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

artículo científico publicado en 2014

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

article

Liver enzyme CYP2D6 gene and tardive dyskinesia

scientific article published on 24 September 2020

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach

artículo científico publicado en 2019

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

artículo científico publicado en 2014

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

artículo científico publicado en 2009

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine

artículo científico publicado en 2016

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

artículo científico publicado en 2010

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response

artículo científico publicado en 2015

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

artículo científico publicado en 2014

Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain

artículo científico publicado en 2011

SU3. Preliminary Study for Association of Genome-Wide Significant Glutamate Receptor Schizophrenia Risk Variants With Clozapine Response.

artículo científico publicado en 2017

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia

scientific article published on 11 May 2020

Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia

artículo científico publicado en 2005

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2.

artículo científico publicado en 2018

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism

artículo científico publicado en 2012

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study

artículo científico publicado en 2021

The catechol-O-methyl-transferase gene in tardive dyskinesia

artículo científico publicado en 2010

The pharmacogenetics of antipsychotic-induced adverse events

artículo científico publicado en 2013

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response

artículo científico publicado en 2011

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

artículo científico publicado en 2012

The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain

artículo científico publicado en 2015

Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics

scientific article published on 06 September 2019

Lista de obras de

A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia

A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia

Analysis of 34 candidate genes in bupropion and placebo remission

Antidepressant-Associated Mania in Bipolar Disorder: A Review and Meta-analysis of Potential Clinical and Genetic Risk Factors

Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia

Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis

Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.

Association of orexin receptor polymorphisms with antipsychotic-induced weight gain

Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans.

Association study between the neurexin-1 gene and tardive dyskinesia

Association study between variants of AMP-activated protein kinase catalytic and regulatory subunit genes with antipsychotic-induced weight gain

Association study of 12 polymorphisms spanning the dopamine D(2) receptor gene and clozapine treatment response in two treatment refractory/intolerant populations

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia

Association study of GABAA α2 receptor subunit gene variants in antipsychotic-associated weight gain

Association study of polymorphisms in cholecystokinin gene and its receptors with antipsychotic induced weight gain in schizophrenia patients

Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients

Association study of tardive dyskinesia and twelve DRD2 polymorphisms in schizophrenia patients

Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia

Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia

Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis

Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia

Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain

F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS.

Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine

Genetic interactions in the adrenergic system genes: analysis of antipsychotic-induced weight gain

Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia

Genetic study of eight AKT1 gene polymorphisms and their interaction with DRD2 gene polymorphisms in tardive dyskinesia

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia

Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain

Genetic variation in CYP3A43 is associated with response to antipsychotic medication

Genetic variation in the GCG and in the GLP1R genes and antipsychotic-induced weight gain

Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans

HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis

Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain

Investigation of TSPO variants in schizophrenia and antipsychotic treatment outcomes

Investigation of melanocortin system gene variants in antipsychotic-induced weight gain

Investigation of the Gene in Tardive Dyskinesia - New Data and Meta-Analysis

Liver enzyme CYP2D6 gene and tardive dyskinesia

New insights into tardive dyskinesia genetics: Implementation of whole-exome sequencing approach

No evidence for a role of the peroxisome proliferator-activated receptor gamma (PPARG) and adiponectin (ADIPOQ) genes in antipsychotic-induced weight gain

Oxidative stress in tardive dyskinesia: genetic association study and meta-analysis of NADPH quinine oxidoreductase 1 (NQO1) and Superoxide dismutase 2 (SOD2, MnSOD) genes

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine

Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis

Preliminary evidence for association of genome-wide significant DRD2 schizophrenia risk variant with clozapine response

Protein kinase cAMP-dependent regulatory type II beta (PRKAR2B) gene variants in antipsychotic-induced weight gain.

Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain

SU3. Preliminary Study for Association of Genome-Wide Significant Glutamate Receptor Schizophrenia Risk Variants With Clozapine Response.

Schizophrenia-associated gene dysbindin-1 and tardive dyskinesia

Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia

T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2.

The AmpliChip® CYP450 test and response to treatment in schizophrenia and obsessive compulsive disorder: a pilot study and focus on cases with abnormal CYP2D6 drug metabolism

The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study

The catechol-O-methyl-transferase gene in tardive dyskinesia

The pharmacogenetics of antipsychotic-induced adverse events

The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response

The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain

The role of genetic variation across IL-1β, IL-2, IL-6, and BDNF in antipsychotic-induced weight gain

Towards precision medicine in generalized anxiety disorder: Review of genetics and pharmaco(epi)genetics